Colliers Securities Sticks to Its Buy Rating for Global Medical REIT (GMRE)

Colliers Securities analyst Barry Oxford maintained a Buy rating on Global Medical REIT (GMREResearch Report) today and set a price target of $19.00. The company’s shares closed last Monday at $15.70.

According to, Oxford is a 4-star analyst with an average return of 15.9% and a 72.9% success rate. Oxford covers the Financial sector, focusing on stocks such as Alpine Income Property Trust Inc, Preferred Apartment Communities, and Bluerock Residential Growth.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Global Medical REIT with a $18.50 average price target, which is a 17.0% upside from current levels. In a report released yesterday, BMO Capital also maintained a Buy rating on the stock with a $18.50 price target.

See Insiders’ Hot Stocks on TipRanks >>

Global Medical REIT’s market cap is currently $1.07B and has a P/E ratio of 101.68.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Read More on GMRE:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed